A virus does not wait for bureaucracy. The Ebola outbreak spreading in the Democratic Republic of the Congo and now reaching Uganda has prompted the U.S. Centers for Disease Control and Prevention to tap emergency reserves—$107 million in fresh funding, a figure that speaks volumes about the severity of what is unfolding on the ground. Yet we must distinguish sharply between announcement and action: emergency funds are meaningful only if they move swiftly to where they are needed, and history teaches us that the path from Washington to remote health centers in Central Africa is neither short nor smooth. The outbreak itself remains poorly characterized in the public record—case numbers, mortality rates, strain identification—the very facts that would let us gauge whether this is a contained flare-up or a spreading threat.

What we know, with reasonable confidence, is that Ebola continues to emerge from animal reservoirs in this region with grim regularity. Each outbreak teaches us something about viral ecology and human vulnerability. The funding decision itself reflects a hard-won lesson: early intervention is far cheaper than late mobilization. Yet the real test lies not in the amount but in the speed and precision of deployment—whether those dollars reach qualified personnel, diagnostic equipment, and isolation facilities before exponential transmission takes hold. The science of outbreak control is well established; the challenge has always been logistical and political.

What troubles me, beneath the headlines, is a deeper question about surveillance and preparedness. Why do we still respond to Ebola as an emergency rather than as a known risk requiring permanent infrastructure? The Congo's health systems remain chronically underfunded, its laboratory capacity fragile, its communication networks unreliable. Throwing money at a crisis, however urgently, is not the same as building resilience. We pour resources into the fire without strengthening the walls. The $107 million is both necessary and, in a truer sense, a measure of our collective failure to invest in stable capacity where outbreaks are almost certain to recur.

The human stakes are immense and immediate: every day of delay costs lives. Yet for those of us tasked with thinking clearly about what this means, the question extends beyond this outbreak. Do we have the honesty to treat epidemic preparedness not as a perpetual emergency but as a permanent commitment to the regions where human and animal life meet in conditions of poverty and weak governance? That is the harder, less glamorous work—and it is where science must speak to power with an urgency that no crisis funding can substitute.